首页> 外文期刊>Journal of Experimental Pharmacology >Evaluation of in vivo antidiabetic, antidyslipidemic and in vitro antioxidant activities of hydromethanolic root extract of Datura stramonium L. (Solanaceae)
【24h】

Evaluation of in vivo antidiabetic, antidyslipidemic and in vitro antioxidant activities of hydromethanolic root extract of Datura stramonium L. (Solanaceae)

机译:曼陀罗(D)(茄科)氢甲醇根提取物的体内抗糖尿病,抗血脂异常和体外抗氧化活性评估

获取原文
       

摘要

Background: The global morbidity and mortality rates of diabetes mellitus are persistently increasing. There is a demand for new antidiabetic drugs because the safety and efficacy of currently available medications are limited. The present study was therefore conducted to study the antidiabetic activities of the hydromethanolic root extract of Datura stramonium L. (Solanaceae) in mice. Methods: Blood glucose lowering activity of three doses (100, 200, and 400 mg/kg) of the hydromethanolic root extract of D. stramonium was tested on normoglycemic, oral glucose-loaded, and streptozotocin (STZ)-induced diabetic mice models. The effect of the extract on body weight and diabetic dyslipidemia was also studied on STZ-induced diabetic mice. Additionally, antioxidant activity of the plant extract was determined using 2,2-diphenyl-1-picrylhydrazine free radical scavenging assay. Data were analyzed using one way ANOVA followed by Tukey’s post hoc multiple comparison test. Results: The hydromethanolic root extract did not show significant hypoglycemic activity in normoglycemic mice. The plant extract at doses of 100, 200, and 400 mg/kg significantly ( P 0.05) reduced blood glucose levels of oral glucose-loaded and diabetic mice. All the three doses of the root extract significantly improved diabetic dyslipidemia and the body weight of diabetic mice. Free radical scavenging activity of the root extract was found to be comparable to ascorbic acid with an IC50 of 13.47 μg/mL. Conclusion: This study demonstrated that the hydromethanolic root extract of D. stramonium possesses significant antidiabetic, antidyslipidemic, and antioxidant activities.
机译:背景:糖尿病的全球发病率和死亡率持续增加。由于目前可用药物的安全性和有效性受到限制,因此需要新的抗糖尿病药。因此,本研究旨在研究曼陀罗(茄科)的氢甲醇根提取物在小鼠中的抗糖尿病活性。方法:在正常血糖,口服葡萄糖负荷和链脲佐菌素(STZ)诱导的糖尿病小鼠模型上测试了三种剂量(100、200和400 mg / kg)的D. stramonium氢甲醇根提取物的降血糖活性。还对STZ诱导的糖尿病小鼠研究了提取物对体重和糖尿病血脂异常的影响。另外,使用2,2-二苯基-1-吡咯肼自由基清除测定法测定植物提取物的抗氧化活性。使用一种方差分析方法进行数据分析,然后进行Tukey事后多重比较测试。结果:在正常血糖小鼠中,氢甲醇根提取物未显示出明显的降血糖活性。分别以100、200和400 mg / kg的剂量提取的植物提取物(P <0.05)降低了口服葡萄糖和糖尿病小鼠的血糖水平。这三剂根提取物均能显着改善糖尿病血脂异常和糖尿病小鼠的体重。发现根提取物的自由基清除活性与抗坏血酸相当,IC50为13.47μg/ mL。结论:本研究表明,D。stramonium的氢甲醇根提取物具有显着的抗糖尿病,抗血脂异常和抗氧化活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号